Latest Asx News

The Takeovers Panel has declined to hear Global Lithium Resources’ review application concerning alleged undisclosed shareholder associations ahead of its upcoming AGM, citing procedural timing issues.

BKI Investment Company Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.039 per share and providing key details on its Dividend Reinvestment Plan (DRP).

Kalgoorlie Gold Mining has confirmed that its recent Lighthorse drilling results at the Pinjin project are material and justified a trading halt before public disclosure. The company received assay data in January and finalized analysis by early February.

Elixir Energy Limited has had its ASX trading suspension lifted following a pivotal announcement about expanding its Taroom Trough assets and initiating a capital raise.

Structural Monitoring Systems’ subsidiary AEM has won full US Forest Service approval for its MTP136D radio, enabling deployment across all federally regulated US aerial firefighting aircraft and setting the stage for significant growth in 2025.

Ryder Capital Limited reports a robust $13.02 million total comprehensive income for 1H FY25, driving a 12.5% increase in its fully franked interim dividend to 4.5 cents per share.

Ryder Capital Limited has announced a fully franked ordinary dividend of AUD 0.045 per share for the half-year ending December 2024, reflecting steady returns to shareholders.

Ryder Capital Limited has reported a striking 312% increase in total comprehensive income for the half-year ended December 31, 2024, alongside a 12.5% hike in its fully franked interim dividend, underscoring robust portfolio performance amid market uncertainties.

Light & Wonder, Inc. has amended its credit agreement to increase its revolving credit facility from $750 million to $1 billion, extend the maturity to 2030, and reduce interest margins based on leverage tests, enhancing its financial flexibility.

Citigroup Global Markets Australia announces a fully franked $1.70 dividend for JBH CitiFirst Instalment MINIs, aligning with JBH Ordinary shares’ record date and ex-dividend schedule.

Memphasys has completed the final patient visit in its Felix™ clinical trial, with data lock expected within two weeks and preliminary results slated for early March 2025. This milestone paves the way for CE Mark submission and imminent commercialisation in Europe.

Elixir Energy Limited's shares have been suspended from trading pending a significant announcement about expanding its Taroom Trough position, signaling potential strategic growth in its energy assets.